Latest and Past News
-
Rendez-vous 2025
The Canadian Hemophilia Society is delighted to invite you to attend Rendez-vous 2025 coming up May 1-4, 2025, in Winnipeg. CLICK HERE for an overview of the event....
-
Biomarin limits marketing of its FVIII gene therapy, Roctavian
SAN RAFAEL, California, August 5, 2024 — Biomarin has announced that it will limit commercial, research and manufacturing programs for its factor VIII gene therapy...
-
Novel treatments in bleeding disorders: The European Haemophilia Consortium Review
CLICK HERE to access the 2024 ISSUE TWO of the periodic review of novel treatments in hemophilia and other bleeding disorders by the European Haemophilia...
-
Contributing to the advancement of scientific knowledge
PREAMBLE We have already come to the end of this important series of articles about the national board and operational committees on which our volunteers...
-
The value in sharing our strengths
PREAMBLE In our special series of articles on the numerous committees our volunteers sit on, it is our pleasure to now present you the International...
-
Playing a key role in shaping the future of people living with bleeding disorders
PREAMBLE In our special series of articles on the numerous committees our volunteers sit on, it is our pleasure to now present you the latest...
-
Bringing experience and knowledge to the ongoing strength and effectiveness of the CHS
PREAMBLE In our special series of articles on the numerous committees our volunteers sit on, it is our pleasure to now present you the Finance...
-
Don’t ever turn your back on your dreams!
My name is Andrea, and I am the mom to my son Nicklas, who has severe hemophilia A. I am writing today to share a...
-
The Care and Treatment Committee … essential to the maintenance and improvement of comprehensive care in Canada
PREAMBLE In our special series of articles on the numerous committees our volunteers sit on, it is our pleasure to now present you the Care...
-
WFH World Congress: so much to learn in so little time!
For many years I coordinated the publication of articles written by participants who had attended the WFH World Congresses for the CHS newsmagazine, Hemophilia Today....
-
Conflicting opinions on gene therapies from Canada’s two HTA agencies
Montreal, July 5, 2024 – Canada’s two health technology assessment (HTA) agencies have made conflicting recommendations on two gene therapies for hemophilia B. Earlier in...
-
A comforting sense of global community
I had the privilege of attending the WFH 2024 World Congress in Madrid, Spain, last April, as a CHS Québec Chapter bursary recipient. From the...
-
What if we knew then what we know now?
The WFH 2024 World Congress was not your father’s conference! For one reason or another, I have been fortunate to attend almost every WFH World...
-
Canadian physiotherapists contributed actively at the WFH 2024 World Congress
We had a great Canadian physiotherapy contingent in Spain for the WFH 2024 World Congress. Six physiotherapists (PTs) from across Canada (Montréal, Toronto, Hamilton, Winnipeg,...